Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2006
11/16/2006WO2006122295A2 Methods of monitoring functional status of transplants using gene panels
11/16/2006WO2006122288A2 Estimating allele frequencies by small pool pcr
11/16/2006WO2006122277A2 Novel targets for the identification of antibiotics that are not susceptible to antibiotic resistance
11/16/2006WO2006122224A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
11/16/2006WO2006122215A2 Methods of mapping polymorphisms and polymorphism microarrays
11/16/2006WO2006122214A2 NOVEL STEROID 5 α -REDUCTASE
11/16/2006WO2006122208A1 Snapback oligonucleotide probe
11/16/2006WO2006122144A2 Methods and compositions for pdgf-d activation and inhibition
11/16/2006WO2006122090A2 Screening assays for compounds regulating dj-i expression
11/16/2006WO2006122049A2 Pna probes for detecting mollicutes
11/16/2006WO2006122002A2 Multiplex capture of nucleic acids
11/16/2006WO2006121997A2 Self-contained biological analysis
11/16/2006WO2006121991A2 Compositions and methods for detection, prognosis and treatment of breast cancer
11/16/2006WO2006121952A2 Diagnostic biomarkers for neurodevelopmental disorders
11/16/2006WO2006121888A2 Methods of nucleic acid target capture
11/16/2006WO2006121866A2 Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences
11/16/2006WO2006121807A2 Assay for cytochrome p450 isoform 2c8
11/16/2006WO2006121773A2 Compositions and assays to detect influenza virus a and b nucleic acids
11/16/2006WO2006121764A2 Multiple capillary device and method for synthesis and dispensing
11/16/2006WO2006121710A2 Bladder cancer biomarkers and uses thereof
11/16/2006WO2006121331A1 Use of ammonium and phosphate ions for improving the detection of luciferase
11/16/2006WO2006121312A1 Genetic polymorphisms associated with myocardial infarction and uses thererof
11/16/2006WO2006121295A1 Method for quantitative analysis of methyl cytosine in dna and uses thereof
11/16/2006WO2006121277A1 Fret probes for fluorescent detection of the epsps gene
11/16/2006WO2006121266A1 Digital bio disc(dbd), dbd driver apparatus, and assay method using the same
11/16/2006WO2006121230A1 Fabrication of carbohydrate chips by immobilizing unmodified carbohydrates on derivatized solid surfaces, and their uses
11/16/2006WO2006121208A1 Polymorphisms of the e2f-1 binding element and methods of determining cancer susceptibility
11/16/2006WO2006121168A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006WO2006121136A1 Method for determination of endoplasmic reticulum stress
11/16/2006WO2006121134A1 Primer and probe for use in detection of mycobacterium kansasii and method for detection of mycobacterium kansasii using the same
11/16/2006WO2006120976A1 Protein cleavage method and use thereof
11/16/2006WO2006120924A1 Cell observation apparatus, method of cell observation and cell observation program
11/16/2006WO2006120423A1 Affinity adsorbents for plasminogen
11/16/2006WO2006120406A2 Gene over-expression in d. discoideum for identifying farnesyl diphosphate synthase antagonists useful for treating bone diseases
11/16/2006WO2006120274A1 Method for the identification of compounds and/or mixtures of compounds that provide photoprotection for the skin against ultraviolet (uv) rays
11/16/2006WO2006119983A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/16/2006WO2006119905A1 Use of a gip promoter polymorphism
11/16/2006WO2006119888A2 Butyrylcholinesterase as target/marker for insulin resistance
11/16/2006WO2006119872A1 Process for producing ligands, ligands and test kit
11/16/2006WO2006119569A1 Methods of enriching fetal cells
11/16/2006WO2006097233A3 Determination of antibiotic resistance in staphylococcus aureus
11/16/2006WO2006094678A3 Method for measuring and comparing the activity of biologically active compounds
11/16/2006WO2006092286B1 Marker solution to be applied by means of an inkjet printer
11/16/2006WO2006089091A3 Methods for detecting minimum residual disease
11/16/2006WO2006088962A9 Replikin peptides and uses thereof
11/16/2006WO2006083986A3 Biomarkers for tissue status
11/16/2006WO2006079934A3 Inhibition of sweat malodour
11/16/2006WO2006078940A3 Allosteric control of proteins by manipulating mechanical tension
11/16/2006WO2006065967A3 Allosteric enzyme coupled immunoassay (aecia)
11/16/2006WO2006062870A3 Food freshness sensor
11/16/2006WO2006060595A3 Reverse two hybrid system for identification of interaction domains
11/16/2006WO2006053245A3 Retroviral vectors with introns
11/16/2006WO2006051397A3 Oligonucleotide probes
11/16/2006WO2006034485A3 Treatment for age-related cognitive decline and other conditions
11/16/2006WO2006027696B1 Process to obtain a molecular marker to determine the sex type in borojo plants
11/16/2006WO2006009933A3 Cdk9 as modifier of the igf pathway and methods of use
11/16/2006WO2006005081A3 Compositions and methods for identifying nucleotides in polynucleotide sequences
11/16/2006WO2005123993A3 Phage microarray profiling of the humoral response to disease
11/16/2006WO2005113819A3 System and method for smoothing melting curve data
11/16/2006WO2005100995A3 Methods of determining allergen response using microarray imminoassay techinques
11/16/2006WO2005083117A8 A novel dna marker for drought tolerance in plants
11/16/2006WO2005082020A8 Flavivirus vaccines
11/16/2006WO2005021729A3 Inhibiting cellular proliferation by way of mixed lineage kinases
11/16/2006WO2004092330A3 Method of generating long nucleic acid molecules of defined sequence
11/16/2006WO2003087129A3 Immunogenic peptides, and method of identifying same
11/16/2006US20060259996 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders
11/16/2006US20060259995 Proteases, nucleic acids encoding them and methods for making and using them
11/16/2006US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006US20060259991 Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases
11/16/2006US20060259990 Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases
11/16/2006US20060259986 Truncated fragments of alpha-synuclein in Lewy Body Disease
11/16/2006US20060259874 System, method, and computer software product for linked window interfaces
11/16/2006US20060259248 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer
11/16/2006US20060259246 Methods for efficiently mining broad data sets for biological markers
11/16/2006US20060258856 Method of isolating nucleic acids from stool samples
11/16/2006US20060258855 High resolution analysis of genetic variation within cryptosporidium parvum
11/16/2006US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006US20060258607 Ghrelin binding nucleic acids
11/16/2006US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006US20060258002 Scanned image alignment systems and methods
11/16/2006US20060257989 Truncated aggrecanase molecules
11/16/2006US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/16/2006US20060257971 Antibodies to pro1561 polypeptide
11/16/2006US20060257969 Methods for determining contamination of fluid compositions
11/16/2006US20060257968 Portable device for detection of microorganisms
11/16/2006US20060257967 Chromogenic plating media for the identification of Enterobacter sakazakii
11/16/2006US20060257966 Medium for detection and identification of micro-organisms
11/16/2006US20060257965 Extracellular matrix signalling molecules
11/16/2006US20060257964 Method of measuring the concentration of hydrogen peroxide, peroxyacetic acid, chlorinated compounds and other aqueous oxidizer compounds
11/16/2006US20060257963 Biotinidase deficiency; metabolic disorders, amino acidopathy, fatty acid oxidation disorder and/or an organic acid disorder; contacting sample comprising biotinidase and one or more amino acids or carnitines with biocytin and protease inhibitors to generate biotin and lysine; mass spectrometry
11/16/2006US20060257962 High sensitivity assay for detection of nucleoside diphosphate production
11/16/2006US20060257961 Sialic acid permease system
11/16/2006US20060257960 Method of estimating drug metabolic activity by analyzing mutations in glucuronosyl transferase gene
11/16/2006US20060257959 Glucose dehydrogenase
11/16/2006US20060257955 Method for detecting escherichia coli
11/16/2006US20060257953 Artificial antibody polypeptides
11/16/2006US20060257948 determining whether a treatment of a disorder with an HDAC inhibitor is to be started/continued or not by determining the level of histone acetylation in the sample using an antibody capable of binding to acetylated histone
11/16/2006US20060257939 Spatially addressable combinatorial chemical array in cd-rom format